BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 7993725)

  • 41. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Disseminated intravascular coagulation syndrome and protein C].
    Kvasnicka J; Ehler Z; Polívková J; Krska Z; Hájek Z; Malíková I; Horák P
    Sb Lek; 2002; 103(2):257-64. PubMed ID: 12688150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical value of antithrombin III].
    Vinazzer H; Bergmann H; Blauhut B
    Wien Med Wochenschr; 1984 Jun; 134(12):279-83. PubMed ID: 6380122
    [No Abstract]   [Full Text] [Related]  

  • 44. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
    Peyrin JC; Waldmann V; Girardet P; Pouzol P; Duret J; Fargnoli JM; Magne JL; Perron Y
    J Chir (Paris); 1986; 123(6-7):417-23. PubMed ID: 3771670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disseminated intravascular coagulation and related syndromes: a clinical review.
    Bick RL
    Semin Thromb Hemost; 1988 Oct; 14(4):299-338. PubMed ID: 3057630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Disseminated intravascular coagulation and sepsis].
    Sevcík P; Matýsková M; Penka M; Táborská D
    Vnitr Lek; 1991 May; 37(5):514-7. PubMed ID: 1842151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management.
    Bick RL
    Clin Lab Med; 1994 Dec; 14(4):729-68. PubMed ID: 7874869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Substitution of antithrombin III in shock and consumption coagulopathy].
    Blauhut B; Bergmann H; Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):879-81. PubMed ID: 6528617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.
    Büller HR; ten Cate JW
    Thromb Haemost; 1983 Apr; 49(2):128-31. PubMed ID: 6868009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pathogenesis and management of disseminated intravascular coagulation.
    Saba HI; Morelli GA
    Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disseminated intravascular coagulation.
    Wada H
    Clin Chim Acta; 2004 Jun; 344(1-2):13-21. PubMed ID: 15149867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Newborn infants and disseminated intravascular coagulation].
    Yamada K
    Rinsho Byori; 1985 Jun; Spec No 63():183-9. PubMed ID: 3930815
    [No Abstract]   [Full Text] [Related]  

  • 54. [Freshly frozen preserved plasma for the treatment of intravascular coagulation in polytraumatized patients].
    Hehne HJ; Nyman D; Burri H; Wolff G
    Schweiz Med Wochenschr; 1976 May; 106(20):671-6. PubMed ID: 996489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disseminated intravascular coagulation(DIC)].
    Udvardy M
    Orv Hetil; 2001 Oct; 142(41):2243-50. PubMed ID: 11760467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Etiology, clinical significance and therapy of antithrombin III deficiencies].
    Lechner K; Thaler E; Niessner H
    Acta Med Austriaca; 1983; 10(5):129-35. PubMed ID: 6666509
    [No Abstract]   [Full Text] [Related]  

  • 57. Disseminated intravascular coagulation: a review of its pathogenesis, manifestations and treatment.
    Moore DJ
    J S Afr Vet Assoc; 1979 Dec; 50(4):259-64. PubMed ID: 399975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin III concentration (Immuno) in the intravascular coagulation syndrome].
    Palareti G; Legnani C; Ludovici S; Maccaferri M
    Haematologica; 1990; 75 Suppl 2():21-32. PubMed ID: 2201605
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R; Stannigel H; Göbel U
    Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The obstetric patient and disseminated intravascular coagulation.
    Weiner CP
    Clin Perinatol; 1986 Dec; 13(4):705-17. PubMed ID: 3539446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.